Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Obstructive sleep apnea (OSA)	$ 127,548	$ 67,923
Total revenues	127,548	67,923
Costs and expenses:
Costs of revenues	64,909	41,660
General and administrative	596,065	425,804
Depreciation and amortization	311	205
Total costs and expenses	661,285	467,669
Loss from operations	(533,737)	(399,746)
Other income (expense):
Interest expense	(394,629)	(328,015)
Interest income	20
Total other income (expense)	(394,609)	(328,015)
Income taxes
Net loss	$ (928,346)	$ (727,761)
PER SHARE INFORMATION
Net Loss Per Common Share	$ (0.01)	$ (0.01)
Weighted Average Number of Common Shares Outstanding	71,661,656	69,690,545